serabelisib   

GtoPdb Ligand ID: 8969

Synonyms: INK 1117 | INK-1117 | INK1117 | MLN 1117 | MLN1117
Compound class: Synthetic organic
Comment: Serabelisib (INK-1117) is a potent and selective orally available phosphatidylinositol-3-kinase (PI3K) inhibitor, being investigated for its potential antineoplastic activity. This is compound 54 in patent US20130035324 [1].
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 98.89
Molecular weight 363.13
XLogP 1.65
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
Isomeric SMILES Nc1oc2c(n1)cc(cc2)c1ccc2n(c1)c(cn2)C(=O)N1CCOCC1
InChI InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22)
InChI Key BLGWHBSBBJNKJO-UHFFFAOYSA-N
Classification
Compound class Synthetic organic
IUPAC Name
[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone
International Nonproprietary Names
INN number INN
10369 serabelisib
Synonyms
INK 1117 | INK-1117 | INK1117 | MLN 1117 | MLN1117
Comments
Serabelisib (INK-1117) is a potent and selective orally available phosphatidylinositol-3-kinase (PI3K) inhibitor, being investigated for its potential antineoplastic activity. This is compound 54 in patent US20130035324 [1].
Database Links
CAS Registry No. 1268454-23-4 (source: SciFinder)
GtoPdb PubChem SID 310264749
PubChem CID 70798655
Search Google for chemical match using the InChIKey BLGWHBSBBJNKJO-UHFFFAOYSA-N
Search Google for chemicals with the same backbone BLGWHBSBBJNKJO
Search PubMed clinical trials serabelisib
Search PubMed titles serabelisib
Search PubMed titles/abstracts serabelisib
Search UniChem for chemical match using the InChIKey BLGWHBSBBJNKJO-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone BLGWHBSBBJNKJO